Skip to content
10-Q

Quarterly Report

PHARMOS CORP

0001513160-12-000050

← back to feed
Filed
Jul 30, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Jul 30, 2012 60.17M sh
Capex Q2 2012 · Jun 30, 2012 $0
Capex Q2 2012 · Jun 30, 2011 $1.6K
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$1.02M
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$1.02M
Cash And Equivalents Q2 2012 · Jun 30, 2012 $517.34K
Cash And Equivalents Q2 2012 · Dec 31, 2011 $1.54M
Cash And Equivalents Q2 2012 · Jun 30, 2011 $2.12M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $3.14M
Stockholders Equity Q2 2012 · Jun 30, 2012 −$539.69K
Stockholders Equity Q2 2012 · Dec 31, 2011 $301.15K
Current Liabilities Q2 2012 · Jun 30, 2012 $1.17M
Current Liabilities Q2 2012 · Dec 31, 2011 $1.36M
Total Liabilities Q2 2012 · Jun 30, 2012 $1.17M
Total Liabilities Q2 2012 · Dec 31, 2011 $1.36M
Current Assets Q2 2012 · Jun 30, 2012 $631.03K
Current Assets Q2 2012 · Dec 31, 2011 $1.66M
Total Assets Q2 2012 · Jun 30, 2012 $634.3K
Total Assets Q2 2012 · Dec 31, 2011 $1.66M
Sga Expense Q2 2012 · Jun 30, 2012 $237.75K
Sga Expense Q2 2012 · Jun 30, 2012 $497.81K
Sga Expense Q2 2012 · Jun 30, 2011 $259.42K
Sga Expense Q2 2012 · Jun 30, 2011 $553.76K
Rd Expense Q2 2012 · Jun 30, 2012 $114.86K
Rd Expense Q2 2012 · Jun 30, 2012 $405.52K
Rd Expense Q2 2012 · Jun 30, 2011 $214.47K
Rd Expense Q2 2012 · Jun 30, 2011 $496.25K
Net Income Q2 2012 · Jun 30, 2012 −$382.88K
Net Income Q2 2012 · Jun 30, 2012 −$959.18K
Net Income Q2 2012 · Jun 30, 2011 −$500.43K
Net Income Q2 2012 · Jun 30, 2011 −$1.1M
Operating Income Q2 2012 · Jun 30, 2012 −$353.22K
Operating Income Q2 2012 · Jun 30, 2012 −$904.56K
Operating Income Q2 2012 · Jun 30, 2011 −$474.56K
Operating Income Q2 2012 · Jun 30, 2011 −$1.05M